Why Zscaler Is Bombing on Q4 Results
Zscaler shares tanked early Wednesday even though it released better than expected fiscal fourth-quarter financial results late Tuesday.
All Work
Chris Lange
Short Sellers Hike Their Bets in Biotech
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Is This Quarter Game Over For GameStop?
GameStop released its fiscal second quarter financial results after the markets closed on Tuesday. The video game retailer said that it had a net loss of $0.32 per share and $1.3 billion in revenue,…
NYC Is Looking to Take a Bite Out of Chipotle
New York is looking to take a bite out the Chipotle in a recent lawsuit filed against the burrito chain. The lawsuit alleges that Chipotle violated New York City’s Fair Workweek Law which went…
Great News for Patients With Dangerously Low Blood Sugar
Xeris Pharmaceuticals shares were halted briefly on Tuesday after the firm announced that it has received regulatory approval from the FDA for Gvoke, its treatment of severe hypoglycemia in pediatric and adult patients with…
Is the FDA Canceling This Schizophrenia Treatment?
Intra-Cellular Therapies shares dipped on Tuesday after the firm released a disappointing update from the FDA concerning its treatment for schizophrenia.
What to Watch When GameStop Reports After the Close
GameStop is scheduled to release its fiscal second-quarter financial results after the markets close on Tuesday, and expectations are low.
Will Wendy’s Choke on Its New Breakfast Expansion?
Wendy’s is moving back into breakfast with its most recent business update. The burger chain announced that it plans to launch its breakfast menu, currently available in more than 300 restaurants, across the U.S.…
Why Francesca’s Is Tuesday’s Top Retailer
Francesca’s may not be a household name like Walmart, Target or other major retailers. However, its shares were absolutely beating every other retailer in the market early Tuesday.
Amgen’s Lung Cancer Study Needs to Take a Breather
Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in patients with…
What One Analyst Has to Say About Apple Ahead of the iPhone 11 Unveiling
Apple is set to unveil the next generation of iPhone. The iPhone 11s represents the next step in the company's ability to put a fence around its unparalleled consumer installed base.
Surprising Reaction to Lung Cancer Study Results
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer.
Goldman Sachs Almost Gets a Challenger on Its $1000 Chipotle Target
Chipotle easily has been one of 2019’s best-performing stocks, with shares nearly doubling in this time. As a result, analysts have been chasing the burrito chain higher.
Sohu Moves to Acquire Changyou
Changeyou.com shares made a massive gain on Monday after the firm said that it had received an acquisition offer from Sohu.com.
Why This New Dementia Study Is a Huge Hit
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Broadcom, Dave & Busters, Kroger, Zscaler and More Earnings Coming This Week
24/7 Wall St. has put together a preview of the most prominent earnings reports expected this week, including Broadcom and Kroger.
New Cellulite Study Submission Could Be a Big Hit
Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in the buttocks.
Why Analysts Are Growing More Optimistic on Lululemon
So far Lululemon has been on a tear in 2019, with shares up about 55%, and after its earnings report it doesn’t seem like the stock will stop anytime soon. Analysts were quick to…
CrowdStrike Just Couldn’t Get It Together in Q2
CrowdStrike shares pulled back Friday after it reported its fiscal second quarter after the markets closed on Thursday.
DocuSign Wows Investors With Q2 Results
DocuSign shares surged even though it released mixed fiscal second-quarter financial results late on Thursday.